Mike Freer
Main Page: Mike Freer (Conservative - Finchley and Golders Green)Department Debates - View all Mike Freer's debates with the Cabinet Office
(8 years, 7 months ago)
Commons ChamberRead Full debate Read Hansard Text Read Debate Ministerial Extracts
David Mundell
I note the inherent contradiction in SNP Members’ position, because every argument its members use for Scotland remaining in the EU is an argument that was dismissed when it related to Scotland remaining in the United Kingdom. However, on this occasion I will forgive them because, like them, I believe that it is in Scotland’s best interests to remain in the EU.
Mike Freer (Finchley and Golders Green) (Con)
Mrs Freer, a pensioner in my right hon. Friend’s constituency, would like to say how pleased she now is to have two Mundells to choose from. She is also seeking reassurance that, as a pensioner, she would be better off in a reformed EU.
David Mundell
I am absolutely clear that the reforms that the Prime Minister brought forward will improve the EU for pensioners and citizens right across Scotland. I also believe that this is not the end of the reform process. The EU is not perfect, even after these reforms, but it is up to the UK to lead in reforming the EU, not to withdraw from it.
The Prime Minister
The hon. Lady raises an important point. That is why we delayed the introduction of this change so that we could look at all the possible consequences and make sure we get it right so that we help vulnerable people.
Mike Freer (Finchley and Golders Green) (Con)
Q12. HIV infection rates in the UK are on the rise. My right hon. Friend will be aware that NHS England has refused to fund a pre-exposure prophylactic treatment. Will he agree to meet me and leading AIDS charities so that we can review this unacceptable decision?
The Prime Minister
It is right that my hon. Friend raises this. My understanding is that NHS England is considering its commissioning responsibility. I want it to reach a decision on this quickly—this month, if possible—because there is no doubt, as he says, that there is a rising rate of infection, and that these treatments can help and make a difference. We are planning trial sites that are already under way, and we are investing £2 million to support them over the next two years. But he is right to raise this, and I will make sure he gets the meetings he needs to make progress with it.